Stratification of patients by clinical stage, lymphovascular invasion, and lymph node metastasis status yielded no significant differences in ST6GAL1 protein expression (Table 1, Figure 2). This evidence concerns the gene ST6GAL1 and metastatic malignant neoplasm in the lymph nodes.